Floatz logo

MOZAFANCOGENE AUTOTEMCEL

Fanconi Anemia Complementation Group A

Rocket Pharmaceuticals Inc.Cell therapyPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Fanconi Anemia Complementation Group A cohort.

Asset / SponsorPhaseRating
Abiraterone Acetate
Qian Qin
Phase 2CCC
PREDNISONE TABLETS
Qian Qin
Phase 2CCC
Docetaxel
Qian Qin
Phase 2CCC
Niraparib
Qian Qin
Phase 2CCC

Same molecule, other indications

MOZAFANCOGENE AUTOTEMCEL is also rated in:

Fanconi anemiaDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →